Basket

1.Kryštály a artropatie - osteoartróza

Kryštály a artropatie - osteoartróza / Duda J. . Rheumatologia : časopis pre otázky pohybového ústrojenstva a spojiva. - ISSN 1210-1931 . - Roč. 25, č. 3 (2011), s. 140

C 2510

article

2.Osteoartróza a mikrokryštály - patogenetické vzťahy

Osteoartróza a mikrokryštály - patogenetické vzťahy / D. Žitňan . Česká revmatologie. - ISSN 1210-7905 . - Roč. 5, č. 1 (1997), s. 57

C 2809

article

3.Hydroxyapatitová kalcifikácia štruktúr pohybového ústrojenstva

Hydroxyapatitová kalcifikácia štruktúr pohybového ústrojenstva / D. Žitňan, J. Duda, J. Rovenský . Rheumatologia : časopis pre otázky pohybového ústrojenstva a spojiva . - Roč. 12, č. 3 (1998), s. 129-138 : Obr., tab.

C 2510

article

4.abciximab

	MeSH Tree Structures - abciximab `[d12.644.541.500.650.125]` aminokyseliny, peptidy a proteíny [d12] + peptidy [d12.644] + fragmenty peptidové [d12.644.541] + fragmenty imunoglobulínov [d12.644.541.500] + Fab fragmenty imunoglobulínov [d12.644.541.500.650] + abciximab `[d12.644.541.500.650.125]` certolizumab pegol [d12.644.541.500.650.250] oblasť imunoglobulínov, variabilná [d12.644.541.500.650.500] + tuftsín [d12.644.541.500.650.750]
	`[d12.776.124.486.485.114.224.060.125]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + imunoproteíny [d12.776.124.486] + imunoglobulíny [d12.776.124.486.485] + protilátky [d12.776.124.486.485.114] + protilátky monoklonálne [d12.776.124.486.485.114.224] + protilátky monoklonálne humanizované [d12.776.124.486.485.114.224.060] + abciximab `[d12.776.124.486.485.114.224.060.125]` adalimumab [d12.776.124.486.485.114.224.060.250] alemtuzumab [d12.776.124.486.485.114.224.060.313] baziliximab [d12.776.124.486.485.114.224.060.344] bevacizumab [d12.776.124.486.485.114.224.060.375] brentuximab vedotin [d12.776.124.486.485.114.224.060.438] certolizumab pegol [d12.776.124.486.485.114.224.060.500] cetuximab [d12.776.124.486.485.114.224.060.750] daklizumab [d12.776.124.486.485.114.224.060.766] denosumab [d12.776.124.486.485.114.224.060.782] gemtuzumab [d12.776.124.486.485.114.224.060.790] inotuzumab ozogamicín [d12.776.124.486.485.114.224.060.794] ipilimumab [d12.776.124.486.485.114.224.060.798] natalizumab [d12.776.124.486.485.114.224.060.813] nivolumab [d12.776.124.486.485.114.224.060.829] omalizumab [d12.776.124.486.485.114.224.060.844] palivizumab [d12.776.124.486.485.114.224.060.860] panitumumab [d12.776.124.486.485.114.224.060.864] ramucirumab [d12.776.124.486.485.114.224.060.866] ranibizumab [d12.776.124.486.485.114.224.060.868] trastuzumab [d12.776.124.486.485.114.224.060.875] + ustekinumab [d12.776.124.486.485.114.224.060.937]
	`[d12.776.124.486.485.680.650.125]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + imunoproteíny [d12.776.124.486] + imunoglobulíny [d12.776.124.486.485] + fragmenty imunoglobulínov [d12.776.124.486.485.680] + Fab fragmenty imunoglobulínov [d12.776.124.486.485.680.650] + abciximab `[d12.776.124.486.485.680.650.125]` certolizumab pegol [d12.776.124.486.485.680.650.250] oblasť imunoglobulínov, variabilná [d12.776.124.486.485.680.650.500] + tuftsín [d12.776.124.486.485.680.650.750]
	`[d12.776.124.790.651.114.224.060.125]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + globulíny sérové [d12.776.124.790] + imunoglobulíny [d12.776.124.790.651] + protilátky [d12.776.124.790.651.114] + protilátky monoklonálne [d12.776.124.790.651.114.224] + protilátky monoklonálne humanizované [d12.776.124.790.651.114.224.060] + abciximab `[d12.776.124.790.651.114.224.060.125]` adalimumab [d12.776.124.790.651.114.224.060.250] alemtuzumab [d12.776.124.790.651.114.224.060.375] baziliximab [d12.776.124.790.651.114.224.060.407] bevacizumab [d12.776.124.790.651.114.224.060.438] brentuximab vedotin [d12.776.124.790.651.114.224.060.469] certolizumab pegol [d12.776.124.790.651.114.224.060.500] cetuximab [d12.776.124.790.651.114.224.060.750] daklizumab [d12.776.124.790.651.114.224.060.766] denosumab [d12.776.124.790.651.114.224.060.782] gemtuzumab [d12.776.124.790.651.114.224.060.790] inotuzumab ozogamicín [d12.776.124.790.651.114.224.060.794] ipilimumab [d12.776.124.790.651.114.224.060.798] natalizumab [d12.776.124.790.651.114.224.060.813] nivolumab [d12.776.124.790.651.114.224.060.829] omalizumab [d12.776.124.790.651.114.224.060.844] palivizumab [d12.776.124.790.651.114.224.060.860] panitumumab [d12.776.124.790.651.114.224.060.864] ramucirumab [d12.776.124.790.651.114.224.060.866] ranibizumab [d12.776.124.790.651.114.224.060.868] trastuzumab [d12.776.124.790.651.114.224.060.875] + ustekinumab [d12.776.124.790.651.114.224.060.937]
	`[d12.776.124.790.651.680.650.125]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + proteíny krvné [d12.776.124] + globulíny sérové [d12.776.124.790] + imunoglobulíny [d12.776.124.790.651] + fragmenty imunoglobulínov [d12.776.124.790.651.680] + Fab fragmenty imunoglobulínov [d12.776.124.790.651.680.650] + abciximab `[d12.776.124.790.651.680.650.125]` certolizumab pegol [d12.776.124.790.651.680.650.250] oblasť imunoglobulínov, variabilná [d12.776.124.790.651.680.650.500] + tuftsín [d12.776.124.790.651.680.650.750]
	`[d12.776.377.715.548.114.224.200.125]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + globulíny [d12.776.377] + globulíny sérové [d12.776.377.715] + imunoglobulíny [d12.776.377.715.548] + protilátky [d12.776.377.715.548.114] + protilátky monoklonálne [d12.776.377.715.548.114.224] + protilátky monoklonálne humanizované [d12.776.377.715.548.114.224.200] + abciximab `[d12.776.377.715.548.114.224.200.125]` adalimumab [d12.776.377.715.548.114.224.200.250] alemtuzumab [d12.776.377.715.548.114.224.200.375] baziliximab [d12.776.377.715.548.114.224.200.407] bevacizumab [d12.776.377.715.548.114.224.200.438] brentuximab vedotin [d12.776.377.715.548.114.224.200.469] certolizumab pegol [d12.776.377.715.548.114.224.200.500] cetuximab [d12.776.377.715.548.114.224.200.750] daklizumab [d12.776.377.715.548.114.224.200.766] denosumab [d12.776.377.715.548.114.224.200.782] gemtuzumab [d12.776.377.715.548.114.224.200.790] inotuzumab ozogamicín [d12.776.377.715.548.114.224.200.794] ipilimumab [d12.776.377.715.548.114.224.200.798] natalizumab [d12.776.377.715.548.114.224.200.813] nivolumab [d12.776.377.715.548.114.224.200.829] omalizumab [d12.776.377.715.548.114.224.200.844] palivizumab [d12.776.377.715.548.114.224.200.860] panitumumab [d12.776.377.715.548.114.224.200.864] ramucirumab [d12.776.377.715.548.114.224.200.866] ranibizumab [d12.776.377.715.548.114.224.200.868] trastuzumab [d12.776.377.715.548.114.224.200.875] + ustekinumab [d12.776.377.715.548.114.224.200.937]
	`[d12.776.377.715.548.680.650.125]` aminokyseliny, peptidy a proteíny [d12] + proteíny [d12.776] + globulíny [d12.776.377] + globulíny sérové [d12.776.377.715] + imunoglobulíny [d12.776.377.715.548] + fragmenty imunoglobulínov [d12.776.377.715.548.680] + Fab fragmenty imunoglobulínov [d12.776.377.715.548.680.650] + abciximab `[d12.776.377.715.548.680.650.125]` certolizumab pegol [d12.776.377.715.548.680.650.250] oblasť imunoglobulínov, variabilná [d12.776.377.715.548.680.650.500] + tuftsín [d12.776.377.715.548.680.650.750]

subject heading

1.Kryštály a artropatie - osteoartróza

2.Osteoartróza a mikrokryštály - patogenetické vzťahy

3.Hydroxyapatitová kalcifikácia štruktúr pohybového ústrojenstva

4.abciximab

MeSH Tree Structures - abciximab

`[d12.644.541.500.650.125]`

`[d12.776.124.486.485.114.224.060.125]`

`[d12.776.124.486.485.680.650.125]`

`[d12.776.124.790.651.114.224.060.125]`

`[d12.776.124.790.651.680.650.125]`

`[d12.776.377.715.548.114.224.200.125]`

`[d12.776.377.715.548.680.650.125]`